ALK Rearrangement in Small-Cell Lung Cancer and Durable Response to Alectinib: A Case Report.

Ning SunYan ZhuangJunling Zhang Shiqing ChenYuwen DaiRenhong Guo

Published in: OncoTargets and therapy (2021)

This case provides a meaningful reference for the treatment of SCLC patients with ALK rearrangement. This case also provides valuable information on the response to ALK inhibitors in patients with ALK-IR rearrangement and better understanding of ALK-TKI applications in the future.

Keyphrases

advanced non small cell lung cancer
small cell lung cancer
epidermal growth factor receptor
healthcare
current status
health information
social media
brain metastases
replacement therapy